Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study.
Miyaoka T, Wake R, Furuya M, Liaury K, Ieda M, Kawakami K, Tsuchie K, Taki M, Ishihara K, Araki T, Horiguchi J. Miyaoka T, et al. Among authors: tsuchie k. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jun 1;37(2):222-6. doi: 10.1016/j.pnpbp.2012.02.002. Epub 2012 Feb 10. Prog Neuropsychopharmacol Biol Psychiatry. 2012. PMID: 22349578 Clinical Trial.
Minocycline improves recognition memory and attenuates microglial activation in Gunn rat: a possible hyperbilirubinemia-induced animal model of schizophrenia.
Liaury K, Miyaoka T, Tsumori T, Furuya M, Hashioka S, Wake R, Tsuchie K, Fukushima M, Limoa E, Tanra AJ, Horiguchi J. Liaury K, et al. Among authors: tsuchie k. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:184-90. doi: 10.1016/j.pnpbp.2013.12.017. Epub 2014 Jan 2. Prog Neuropsychopharmacol Biol Psychiatry. 2014. PMID: 24389395
Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial.
Miyaoka T, Kanayama M, Wake R, Hashioka S, Hayashida M, Nagahama M, Okazaki S, Yamashita S, Miura S, Miki H, Matsuda H, Koike M, Izuhara M, Araki T, Tsuchie K, Azis IA, Arauchi R, Abdullah RA, Oh-Nishi A, Horiguchi J. Miyaoka T, et al. Among authors: tsuchie k. Clin Neuropharmacol. 2018 Sep/Oct;41(5):151-155. doi: 10.1097/WNF.0000000000000299. Clin Neuropharmacol. 2018. PMID: 30234616 Clinical Trial.
Hyperbilirubinemia-related behavioral and neuropathological changes in rats: a possible schizophrenia animal model.
Hayashida M, Miyaoka T, Tsuchie K, Yasuda H, Wake R, Nishida A, Inagaki T, Toga T, Nagami H, Oda T, Horiguchi J. Hayashida M, et al. Among authors: tsuchie k. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Jun 15;33(4):581-8. doi: 10.1016/j.pnpbp.2009.02.013. Epub 2009 Feb 26. Prog Neuropsychopharmacol Biol Psychiatry. 2009. PMID: 19249333
Analysis of oxidative stress expressed by urinary level of biopyrrins and 8-hydroxydeoxyguanosine in patients with chronic schizophrenia.
Miyaoka T, Ieda M, Hashioka S, Wake R, Furuya M, Liaury K, Hayashida M, Tsuchie K, Arauchi R, Araki T, Shioji I, Ezoe S, Inoue K, Yamaguchi T, Horiguchi J. Miyaoka T, et al. Among authors: tsuchie k. Psychiatry Clin Neurosci. 2015 Nov;69(11):693-8. doi: 10.1111/pcn.12319. Epub 2015 Jul 14. Psychiatry Clin Neurosci. 2015. PMID: 25975810 Free article.
38 results